Literature DB >> 8218159

Amino acids of the recombinant kringle 1 domain of human plasminogen that stabilize its interaction with omega-amino acids.

G J Hoover1, N Menhart, A Martin, S Warder, F J Castellino.   

Abstract

A series of strategically designed recombinant (r) mutants of the kringle 1 region of human plasminogen ([K1HPg]) have been constructed and the resulting gene products employed to reveal the identities of the residues that contribute to stabilization of the binding of omega-amino acid ligands to this domain. On the basis of determinations of the binding constants of the ligands, 6-aminohexanoic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic acid, to a variety of these mutants, we find that the anionic site of the polypeptide responsible for stabilization of the amino group of the ligands consists of both D54 and D56 and the cationic site of the polypeptide that interacts with the carboxylate group of the ligand is composed solely of R70. The main hydrophobic interactions that stabilize binding of these ligands, likely by interactions with the ligand hydrophobic regions, are principally due to W61, Y63, and Y71. The results obtained are consistent with conclusions that could be made from analysis of the X-ray crystal structure of r-[K1HPg] and from previous studies from this laboratory regarding the binding of ligands of this type to the kringle 2 region of tissue-type plasminogen activator ([K2tPA]). It thus appears as though a common ligand binding site has evolved in different kringles with ligand specificity differences between r-[K2tPA] and r-[K1HPg] perhaps explainable by the different nature of the cationic sites on these polypeptides that are involved in coordination to the ligand carboxylate groups.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218159     DOI: 10.1021/bi00092a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Tranexamic acid suppresses the release of mitochondrial DNA, protects the endothelial monolayer and enhances oxidative phosphorylation.

Authors:  Igor Prudovsky; Damien Carter; Doreen Kacer; Monica Palmeri; Tee Soul; Chloe Kumpel; Kathleen Pyburn; Karyn Barrett; Victoria DeMambro; Ilya Alexandrov; Irina Brandina; Robert Kramer; Joseph Rappold
Journal:  J Cell Physiol       Date:  2019-04-02       Impact factor: 6.384

2.  Kringle-kringle interactions in multimer kringle structures.

Authors:  K Padmanabhan; T P Wu; K G Ravichandran; A Tulinsky
Journal:  Protein Sci       Date:  1994-06       Impact factor: 6.725

3.  Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.

Authors:  Wendy M Mars; Minji Jo; Steven L Gonias
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

4.  Residues essential for plasminogen binding by the cation-independent mannose 6-phosphate receptor.

Authors:  Richard N Bohnsack; Manish Patel; Linda J Olson; Sally S Twining; Nancy M Dahms
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

Review 5.  Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  J Lipid Res       Date:  2015-12-08       Impact factor: 5.922

6.  Structural/functional properties of the Glu1-HSer57 N-terminal fragment of human plasminogen: conformational characterization and interaction with kringle domains.

Authors:  S S An; D N Marti; C Carreño; F Albericio; J Schaller; M Llinas
Journal:  Protein Sci       Date:  1998-09       Impact factor: 6.725

7.  Solution structure of the complex of VEK-30 and plasminogen kringle 2.

Authors:  Min Wang; Jaroslav Zajicek; James H Geiger; Mary Prorok; Francis J Castellino
Journal:  J Struct Biol       Date:  2009-09-30       Impact factor: 2.867

Review 8.  Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination.

Authors:  Sarbani Bhattacharya; Victoria A Ploplis; Francis J Castellino
Journal:  J Biomed Biotechnol       Date:  2012-10-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.